EE554 Costs Comparison Between Dupilumab and Omalizumab in the Treatment of Severe Allergic Asthma in the Brazilian Private Healthcare Perspective
Abstract
Authors
A Barbosa FJB Magro A Taminato P Federico RNT Prioli S Goldflus CB Migliavaca M Falavigna